Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C

MLA

Jacob Lalezari, et al. “Cardiac Dysfunction Associated with a Nucleotide Polymerase Inhibitor for Treatment of Hepatitis C.” Hepatology, vol. 62, May 2015, pp. 409–16. EBSCOhost, https://doi.org/10.1002/hep.27488.

APA

Jacob Lalezari, Monica Kumar, Joann Zamparo, Robert Wolf, B. Freilich, Jeffrey E. Saffitz, Philip D. Yin, Eric Hughes, Adrian F. Hernandez, Kyle Brown, Tariq Ahmad, Margo Heath-Chiozzi, Dessislava Dimitrova, Andrew J. Muir, Doug Manion, Mitchell L. Shiffman, & Paul J. Pockros. (2015). Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. Hepatology, 62, 409–416. https://doi.org/10.1002/hep.27488

Chicago

Jacob Lalezari, Monica Kumar, Joann Zamparo, Robert Wolf, B. Freilich, Jeffrey E. Saffitz, Philip D. Yin, et al. 2015. “Cardiac Dysfunction Associated with a Nucleotide Polymerase Inhibitor for Treatment of Hepatitis C.” Hepatology 62 (May): 409–16. doi:10.1002/hep.27488.